2003
"FDA Underpinning of Paragraph 4 Litigation", Conference of the American Chemistry Society
This event has already occurred.
Related Insights
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA
April 23, 2024
2min
DOJ Announces Pilot Program for Individual Voluntary Self-Disclosures
DOJ Announces Pilot Program for Individual Voluntary Self-Disclosures
April 22, 2024
5min
Erin Austin and Dom Conde Co-Author The Thirteenth Edition of Lexology In-Depth: Intellectual Property
Erin Austin and Dom Conde Co-Author The Thirteenth Edition of Lexology In-Depth: Intellectual Property
April 22, 2024
1min
Events
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
April 25 - 26, 2024 New York, NY - American Conference Institute
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
April 25, 2024 Washington, DC - Venable
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
May 01 - 03, 2024 New Orleans, LA - Financial Counseling Association of America (FCAA)